Blockade of Vascular Endothelial Growth Factor Receptor 1 Prevents Inflammation and Vascular Leakage in Diabetic Retinopathy
Diabetic retinopathy (DR) is a leading cause of blindness in working age adults. The objective of this study is to investigate the effects of vascular endothelial growth factor receptor 1 (VEGFR1) blockade on the complications of DR. Experimental models of diabetes were induced with streptozotocin (...
Main Authors: | Jianbo He, Hong Wang, Ying Liu, Wen Li, Dorothy Kim, Hu Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | Journal of Ophthalmology |
Online Access: | http://dx.doi.org/10.1155/2015/605946 |
Similar Items
-
Angiogenesis and vascular leakage in diabetic retinopathy
by: Laughlin, William Edward
Published: (2018) -
Diabetic retinopathy and vascular endothelial growth factor
by: Majid Khazaei
Published: (2013-01-01) -
The association study of gene polymorphism of vascular endothelial growth factor with diabetic retinopathy
by: Dong-Hao Li, et al.
Published: (2013-06-01) -
Streptozotocin induced diabetic retinopathy in rat and the expression of vascular endothelial growth factor and its receptor
by: Chen-Yuan Gong, et al.
Published: (2013-10-01) -
Investigation of correlations between vascular endothelial growth factor and proliferative diabetic retinopathy
by: Hong-Li Zhu
Published: (2014-12-01)